| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-15 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-13 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |